Novo Nordisk Submits Higher Dose of Wegovy One in Three Achieves Over 25 Percent Weight Loss
On July 9, 2025, Novo Nordisk announced the submission of a higher-dose formulation of its obesity drug Wegovy to the European Medicines Agency (EMA) for approval. This move marks a significant step in the company’s efforts to expand treatment options for obesity across the European Union.
Clinical trials demonstrated that one in three participants achieved a weight loss of 25% or more, underscoring the enhanced efficacy of the new dosage. Novo Nordisk stated that the higher dose aligns with its mission to provide innovative, patient-focused solutions for individuals living with obesity.
The company aims to make the higher-dose version of Wegovy available across the EU following approval. If successful, this will solidify Wegovy's position as a leading treatment in the obesity drug market.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$169/UNIT FOB
2026-10-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Procter & Gamble Posts Higher Profits on Strong Personal Care Sales and Recovery in China
-
Huntsman Issues Two Consecutive MDI Price Hike Notices: €250 Increase in Europe, $300 Increase in India
-
Lotte Chemical Plans Sale of Selected Operations in Malaysia, Indonesia, and the United States
-
Dover to Acquire Cloeren and Expand Its Polymer-Extrusion Equipment Portfolio
-
GACL Approves Additional Hydrochloric Acid Unit at Dahej
-
Croda’s First-Half Profit Outpaces Sales as Beauty Actives Grow 19%
-
argenx to Acquire Forte Biosciences for $2.2 Billion in Major Autoimmune Antibody Deal
-
Advent Drops Its 2026 Purchase, and LANXESS’s €1.2 Billion Exit Plan Falls Through
-
Wanhua Chemical Establishes a RMB 1.488 Billion New Energy Materials Company in Weifang, Further Integrating Green Power and Battery Materials Businesses
-
BASF Moves to Sell 4,400 Employee Homes—Union Fury Reveals the Survival Math of a Chemical Giant
Recommend Reading
-
![Syngenta Bee Pesticide Protest Shows the Pressure Building Around Crop Protection Giants]()
Syngenta Bee Pesticide Protest Shows the Pressure Building Around Crop Protection Giants
-
![Unable to Buy Entire AkzoNobel, Nippon Paint Begins a]()
Unable to Buy Entire AkzoNobel, Nippon Paint Begins a "Disassembled Approach"
-
![AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities]()
AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities
-
![BASF Builds New Alkyl Polyglucoside Plant in Thailand, Expands Its Business Footprint in Asia]()
BASF Builds New Alkyl Polyglucoside Plant in Thailand, Expands Its Business Footprint in Asia
-
![Semcorp's Hungarian Factory Ordered to Shut Down Over Pollution]()
Semcorp's Hungarian Factory Ordered to Shut Down Over Pollution
-
![Dicalcium Phosphate: Properties, Uses, and Applications]()
Dicalcium Phosphate: Properties, Uses, and Applications
-
![Business Society’s Market Outlook for Ethyl Acetate on August 26, 2026: Strong Consolidation]()
Business Society’s Market Outlook for Ethyl Acetate on August 26, 2026: Strong Consolidation
-
![Business Society’s September 1, 2026 Caustic Soda Market Outlook: Signals of Decline]()
Business Society’s September 1, 2026 Caustic Soda Market Outlook: Signals of Decline
-
![China's Phenol Market Surges 62% in 9 Days]()
China's Phenol Market Surges 62% in 9 Days
-
![Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate]()
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
